Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Medicinova (MNOV)
NASDAQ:MNOV
Medicinova (MNOV) Stock Price & Analysis
273 Followers
MNOV Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.89 - $2.73
Previous Close$1.99
Volume5.37K
Average Volume (3M)21.86K
Market Cap
$97.60M
Enterprise Value$44.93M
Total Cash (Recent Filing)$52.88M
Total Debt (Recent Filing)$201.28K
Price to Earnings (P/E)-7.8
Beta0.70
Next Earnings
Apr 26, 2023EPS Estimate
-$0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.25
Shares Outstanding49,046,246
10 Day Avg. Volume29,025
30 Day Avg. Volume21,862
Standard Deviation0.13
R-Squared0.17
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)1.77
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-4.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-4.67
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Medicinova News
Press ReleasesMediciNova Receives Gene Therapy Milestone Payment
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MNOV FAQ
What was Medicinova’s price range in the past 12 months?
Medicinova lowest stock price was $1.89 and its highest was $2.73 in the past 12 months.
What is Medicinova’s market cap?
Currently, no data Available
When is Medicinova’s upcoming earnings report date?
Medicinova’s upcoming earnings report date is Apr 26, 2023 which is 176 days ago.
How were Medicinova’s earnings last quarter?
Medicinova released its earnings results on Jul 27, 2022. The company reported -$0.15 earnings per share for the quarter, missing the consensus estimate of -$0.087 by -$0.063.
Is Medicinova overvalued?
According to Wall Street analysts Medicinova’s price is currently Overvalued.
Does Medicinova pay dividends?
Medicinova does not currently pay dividends.
What is Medicinova’s EPS estimate?
Medicinova’s EPS estimate is -$0.07.
How many shares outstanding does Medicinova have?
Medicinova has 49,046,246 shares outstanding.
What happened to Medicinova’s price movement after its last earnings report?
Medicinova reported an EPS of -$0.15 in its last earnings report, missing expectations of -$0.087. Following the earnings report the stock price went down -1.835%.
Which hedge fund is a major shareholder of Medicinova?
Among the largest hedge funds holding Medicinova’s share is Caxton Associates LP. It holds Medicinova’s shares valued at N/A.
---
Medicinova Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-2.92%
12-Months-Change
Fundamentals
Return on Equity
-17.55%
Trailing 12-Months
Asset Growth
-15.41%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Medicinova
MediciNova, Inc. is a biopharmaceutical company, which engages in the acquisition and development of small molecule therapeutics for the treatment of serious diseases for the treatment of diseases with unmet medical need. Its development pipeline consists of clinical-stage compounds for the treatment of acute exacerbations of asthma and COPD, progressive multiple sclerosis, methamphetamine addiction, neuropathic pain, asthma, interstitial cystitis, and solid tumor cancers. The company was founded by Yuichi Iwaki on September 26, 2000 and is headquartered in La Jolla, CA.
---
Top 5 ETFs holding MNOV
Dimensional U.S. Core Equity 2 ETF
$45.71K
Dimensional US Core Equity 1 ETF
$40.00
Up to five ETFs with an Outperform Smart Score that hold MNOV. The ETFs are listed according to market value of MNOV within the ETF
Kura Oncology
―
Protagonist Therapeutics
―
Rubius Therapeutics
―
Allogene Therapeutics
―
---